Cargando…
Potential Role of Bupropion Sustained Release for Cancer-Related Fatigue: a Double-Blind, Placebo-Controlled Study
BACKGROUND: Cancer-related fatigue (CRF) is very common and can be experienced at all stages of disease and in survivors. CRF causes patients more distress than pain or nausea and vomiting. Different pharmacologic interventions have been evaluated for the management of CRF. The purpose of this study...
Autores principales: | Ashrafi, Farzaneh, Mousavi, Sarah, Karimi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6103561/ https://www.ncbi.nlm.nih.gov/pubmed/29936730 http://dx.doi.org/10.22034/APJCP.2018.19.6.1547 |
Ejemplares similares
-
Efficacy and safety of bupropion in cancer-related fatigue, a randomized double blind placebo controlled clinical trial
por: Salehifar, Ebrahim, et al.
Publicado: (2020) -
The efficacy and safety of bupropion sustained-release formulation for the treatment of major depressive disorder: a multi-center, randomized, double-blind, placebo-controlled study in Asian patients
por: Koshino, Yoshifumi, et al.
Publicado: (2013) -
Naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Caixàs, Assumpta, et al.
Publicado: (2014) -
Letter to the editor: naltrexone sustained-release/bupropion sustained-release for the management of obesity: review of the data to date
por: Buehler, Anna M
Publicado: (2015) -
Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of Bupropion as Treatment for Methadone-Emergent Sexual Dysfunction in Men
por: Yee, Anne, et al.
Publicado: (2018)